Calosyn Pharma

closed

Biopharmaceutical company developing therapeutics for osteoarthritis.

Launch date

Sep 2007

Employees

Market cap

Enterprise valuation

Atlanta Georgia (HQ)

Date	Investors	Amount	Round
Jun 2009	MB Venture Partners BVM Capital	$400k	Seed
Apr 2010	N/A	$1.9m	Early VC
Feb 2012	N/A	$310k	Early VC
Dec 2022*	N/A	$750k	Debt
Total Funding		$2.6m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Calosyn Pharma